...
首页> 外文期刊>Research Disclosure >Crisaborole (code AN-2728) a non-steroidal boron containing drug is a phosphodiesterase-4 inhibitor, used for topical treatment of psoriasis and atopic dermatitis
【24h】

Crisaborole (code AN-2728) a non-steroidal boron containing drug is a phosphodiesterase-4 inhibitor, used for topical treatment of psoriasis and atopic dermatitis

机译:脆大(代码AN-2728)含有非甾体硼的药物是磷酸二酯酶-4抑制剂,用于局部治疗牛皮癣和特应性皮炎

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Crisaborole (code AN-2728) a non-steroidal boron containing drug is a phosphodiesterase-4 inhibitor, used for topical treatment of psoriasis and atopic dermatitis. The chemical name of crisaborole is 5-(4-cyanophenoxy)-l-hydroxy-l,3-dihydro-2.1-bena)xaborole and has following structure: US8039451B2 discloses Crisaborole and pharmaceutical formulation containing it. US '451 also discloses process for preparation of Crisaborole in example-4. The process disclosed in the patent suffers from several disadvantages, as it utilizes of flash column chromatography to purify the product it is a cumbersome, expensive and time consuming technique. Further the product is obtained in very low yield and has only 80% purityeven after column purification. Hence, one or more purification steps are required to purify the obtained compound in order to comply with various regulatory requirements.
机译:Crisaborole(代码AN-2728)含有的非甾体硼药物是磷酸二酯酶-4抑制剂,用于局部治疗牛皮癣和特应性皮炎。脆梁的化学名称是5-(4-氰基氧基)-1-羟基-1,3-二氢-2.1- Bena)Xaborole,并且具有以下结构:US8039451B2公开了含有其的脆大和药物制剂。美国451还公开了制备实施例-4中的卷轴的方法。在该专利中公开的过程患有若干缺点,因为它利用闪光柱色谱法净化产物,这是一种麻烦,昂贵且耗时的技术。此外,该产物以非常低的产率获得,并且在柱纯化后仅具有80%的puriiteeven。因此,需要一种或多种纯化步骤以纯化所得化合物以符合各种调节要求。

著录项

  • 来源
    《Research Disclosure》 |2019年第658期|140-140|共1页
  • 作者

  • 作者单位
  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号